MitoSciences Licenses Antibody Tech for Cell-based Screening | GenomeWeb
NEW YORK (GenomeWeb News) – MitoSciences has agreed to an exclusive license for monoclonal antibodies from the University of Oregon for use in its cell-based drug toxicity screening tests and multiplexing assays, the Eugene, Ore.-based company said today.
The University will receive royalties from patent-related sales and $4.6 million in fixed quarterly cash payments over 10 years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

In Nature this week: genetic history of HIV in the US, and more.